tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Takeda Pharmaceutical Co Ltd (JP:4502)
:4502
Japanese Market
4502
Takeda Pharmaceutical Co
RESEARCH TOOLSreports

Takeda Pharmaceutical Co (4502) Stock News & Sentiment

Compare
7 Followers
Takeda and Protagonist Win FDA Priority Review for First-in-Class Polycythemia Vera Drug
Premium
Company Announcements
Takeda and Protagonist Win FDA Priority Review for First-in-Class Polycythemia Vera Drug
22d ago
Takeda Wins FDA Priority Review for Potential First-in-Class Narcolepsy Drug
Premium
Company Announcements
Takeda Wins FDA Priority Review for Potential First-in-Class Narcolepsy Drug
1M ago
Takeda Posts Lower Nine-Month Revenue but Higher Profit, Lifts Dividend and Trims Growth Outlook
Premium
Company Announcements
Takeda Posts Lower Nine-Month Revenue but Higher Profit, Lifts Dividend and Trims Growth Outlook
2M ago
TKPHF Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
TKPHF Upcoming Earnings Report: What to Expect?
2M ago
Takeda’s Oral TYK2 Inhibitor Zasocitinib Delivers Strong Phase 3 Psoriasis Results
Premium
Company Announcements
Takeda’s Oral TYK2 Inhibitor Zasocitinib Delivers Strong Phase 3 Psoriasis Results
3M ago
Takeda and Protagonist Showcase Promising Rusfertide Results at ASH 2025
Premium
Company Announcements
Takeda and Protagonist Showcase Promising Rusfertide Results at ASH 2025
4M ago
Takeda Pharmaceutical: Strategic Growth and Favorable Positioning Drive Buy Rating
Premium
Ratings
Takeda Pharmaceutical: Strategic Growth and Favorable Positioning Drive Buy Rating
4M ago
TAK
More JP:4502 News >

4502 News on the Web

Alkermes price target lowered to $43 from $45 at Piper Sandler
TipRanks News
Neutral
Protagonist Therapeutics price target raised to $100 from $86 at Wedbush
TipRanks News
Neutral
Takeda, Protagonist announce FDA acceptance of rusfertide new drug application
TipRanks News
Bullish
Takeda and Protagonist Win FDA Priority Review for First-in-Class Polycythemia Vera Drug
TipRanks News
Bullish
Boston Scientific names Cathy Smith, Christophe Weber to board of directors
TipRanks News
Neutral
Takeda announces data from Phase 3 KEPLER trial of ENTYVIO
TipRanks News
Bullish
Takeda granted Priority Review for oveporexton by FDA
TipRanks News
Bullish
Takeda Wins FDA Priority Review for Potential First-in-Class Narcolepsy Drug
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
JP:4502
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is JP:4502’s Media Buzz Sentiment?
1 articles about JP:4502 were published this week. In an average week, 1 articles are published.
    What is JP:4502’s weekly average amount of articles?
    In an average week, 1 articles about JP:4502 are published.
      What is JP:4502’s News Sentiment?
      50% of articles about JP:4502 were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        HYPRHyperfine
        OVIDOvid Therapeutics
        INNMFAmplia Therapeutics
        ALMSAlumis Inc.
        NWPHFNewron Pharmaceuticals SpA
        Showing the stocks with the most bullish news sentiment over the past week